Jeffrey W Sherman - Net Worth and Insider Trading
Jeffrey W Sherman Net Worth
The estimated net worth of Jeffrey W Sherman is at least $28 Million dollars as of 2024-04-19. Jeffrey W Sherman is the EVP and Chief Medical Officer of Horizon Therapeutics PLC and owns about 236,645 shares of Horizon Therapeutics PLC (HZNP) stock worth over $28 Million. Jeffrey W Sherman is also the Director of Xeris Biopharma Holdings Inc and owns about 113,278 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $195,405. Details can be seen in Jeffrey W Sherman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey W Sherman has not made any transactions after 2023-11-27 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey W Sherman
Jeffrey W Sherman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey W Sherman owns 4 companies in total, including Horizon Therapeutics PLC (HZNP) , Xeris Biopharma Holdings Inc (XERS) , and Strongbridge Biopharma PLC (SBBP) among others .
Click here to see the complete history of Jeffrey W Sherman’s form 4 insider trades.
Insider Ownership Summary of Jeffrey W Sherman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2023-01-11 | EVP & Chief Medical Officer |
| XERS | Xeris Biopharma Holdings Inc | 2023-11-27 | director |
| SBBP | Strongbridge Biopharma PLC | 2020-05-15 | director |
| LRMR | Larimar Therapeutics Inc | 2023-10-03 | director |
Jeffrey W Sherman Latest Holdings Summary
Jeffrey W Sherman currently owns a total of 2 stocks. Among these stocks, Jeffrey W Sherman owns 236,645 shares of Horizon Therapeutics PLC (HZNP) as of January 11, 2023, with a value of $28 Million and a weighting of 99.3%. Jeffrey W Sherman also owns 113,278 shares of Xeris Biopharma Holdings Inc (XERS) as of November 27, 2023, with a value of $195,405 and a weighting of 0.7%.
Latest Holdings of Jeffrey W Sherman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2023-01-11 | 236,645 | 116.30 | 27,521,814 |
| XERS | Xeris Biopharma Holdings Inc | 2023-11-27 | 113,278 | 1.73 | 195,405 |
Holding Weightings of Jeffrey W Sherman
Jeffrey W Sherman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey W Sherman has made a total of 8 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 6,736 shares on January 11, 2023, which brought Jeffrey W Sherman around $761,707.
According to the SEC Form 4 filings, Jeffrey W Sherman has made a total of 1 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 5,400 shares on November 27, 2023, which cost Jeffrey W Sherman around $10,098.
Insider Trading History of Jeffrey W Sherman
- 1
Jeffrey W Sherman Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey W Sherman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey W Sherman is 70.11%. GuruFocus also compares Jeffrey W Sherman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey W Sherman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey W Sherman's insider trading performs compared to the benchmark.
Performance of Jeffrey W Sherman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.64 | 70.11 | ||||
| Relative Return to S&P 500(%) | 18.56 | 58.51 |
Jeffrey W Sherman Ownership Network
Ownership Network List of Jeffrey W Sherman
Ownership Network Relation of Jeffrey W Sherman
Jeffrey W Sherman Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Jeffrey W Sherman is the EVP & Chief Medical Officer of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and Chief Accounting Officer Patrick Mcilvenny .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
Over the past 18 months, Jeffrey W Sherman made 3 insider transaction in Horizon Therapeutics PLC (HZNP) with a net sale of 40,275. Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 57,298 shares made by Andy Pasternak , a net sale of 36,148 shares made by Aaron Cox ,
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Jeffrey W Sherman Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey W Sherman. You might contact Jeffrey W Sherman via mailing address: C/o Idm Pharma, Inc., 9 Parker, Suite 100, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
